Managing the First Mile from Collection to Cryopreservation: Standardizing Starting Material Requirements
Wednesday, May 29, 2024 08:00 AM - 09:00 AM
Room 202-204
Bioprocessing & Manufacturing
Roundtable
Organized by: ISCT Process Development & Manufacturing Committee
Moderator(s)
Key Learning Objectives:
1. To understand the impact of collection practices on downstream preservation.
2. Which components of the cryopreservation process are most critical.
3. Discuss and identify the need for creating best practices for collection and cryopreservation of the leukapheresis starting material.
Moderator(s)
- Lizette Caballero, BS, MT(ASCP), Johnson & Johnson Innovative Medicine, United States
- Dominic Clarke, PhD, Cryoport Systems, United States
- Joseph Schwartz, MD, MPH, Moffitt Cancer Center, United States
- Kathy Loper, MHS, NMDP, United States
- Tracey L. Hlucky, CQA, CMQ/OE (ASQ), Kite Pharma, United States
Key Learning Objectives:
1. To understand the impact of collection practices on downstream preservation.
2. Which components of the cryopreservation process are most critical.
3. Discuss and identify the need for creating best practices for collection and cryopreservation of the leukapheresis starting material.
Lizette Caballero
Associate Director-CTL
Janssen Pharmaceutical Companies of Johnson & Johnson
Co-moderator
Associate Director-CTL
Janssen Pharmaceutical Companies of Johnson & Johnson
Co-moderator
Tracey Hlucky
Senior Manager, Regional Quality Operations- US
Kite Pharma (a Gilead Company)
Panelist
Senior Manager, Regional Quality Operations- US
Kite Pharma (a Gilead Company)
Panelist
